No Association Between Diabetes Drug Rosiglitazone (Avandia) And Increased Rate Of Heart Attack

Links shared publicly online about this topic.

  • 1,056
    total visits

No Association Between Diabetes Drug Rosiglitazone (Avandia) And Increased Rate Of Heart Attack

medicalnewstoday.com

The diabetes drug Avandia (rosiglitazone) has been under intense scrutiny since a study published in the New England Journal of Medicine (NEJM) in 2007 looked at over 40 clinical trials and

View full resource at medicalnewstoday.com

Tags: Heart, Diabetes, Diabetes Type 2 Medication, Diabetes Medication, Drug, Avandia, Avandamet, Avandaryl

  • Share

Most Recently Shared on June 30, 2010 at 9:05 pm By:

mnt_diabetes MNT Diabetes News

No Association Between Diabetes Drug Rosiglitazone (Avandia) And Increased Rate Of Heart Attack http://mnt.to/3Fzm #diabetes

2 years ago...

Also Shared By:

Heart Health Heart Health

Diabetes, Type 2 Diabetes, Type 2

Heart Disease OW Heart Disease OW

MNT Health News MNT Health News


Show More...

Advertisement